FDA Inspection 887354 — Aesica Pharmaceuticals GmbH

Aesica Pharmaceuticals GmbH — FEI 3002948883

The FDA completed an inspection of Aesica Pharmaceuticals GmbH on June 20, 2014 in Zwickau. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 20, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Zwickau (Germany)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
202721 CFR 211.192Investigations of discrepancies, failures